Revvity (BSP:R1VT34) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 25, 2026)


BSP:R1VT34 Revvity Inc BSP:R1VT34
17 GF Score
Price R$19.41
GF Value R$22.14
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Revvity Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Revvity's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

BSP:R1VT34 vs MEDP, ICLR, CRL: Margin of Safety % (DCF FCF Based) Comparison

For the Diagnostics & Research subindustry, Revvity's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Revvity Margin of Safety % (DCF FCF Based) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Revvity's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Revvity's Margin of Safety % (DCF FCF Based) falls into.


BSP:R1VT34
17GF Score
Revvity Inc BSP:R1VT34
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Revvity (BSP:R1VT34) Overvalued in 2026?

Based on GuruFocus' analysis, Revvity stock appears to be undervalued. The current stock price of R$19.41 is trading 12.3% below its estimated GF Value™ of R$22.14. GuruFocus considers Revvity to be Modestly Undervalued.

Key valuation signals for BSP:R1VT34:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: R$22.14 vs. price of R$19.41 (12.3% below fair value)
  • GF Score™: 17/100 with 9 warning signs

No single metric tells the full story. See the BSP:R1VT34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Revvity Business Description

Other Exchanges RVTY:USA0KHE:UKPKN:Germany
Address 77 4th Avenue, Waltham, MA, USA, 02451
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.
17GF Score

Get the complete analysis for BSP:R1VT34

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$19.41
Price
R$22.14
GF Value